Breast cancer cells enticed to spread by 'tumorous environment' as well as genetic changes

October 22, 2012 in Cancer

Breast cancer cells enticed to spread by 'tumorous environment' as well as genetic changes

Two pieces of the same human metastatic breast tumor acted very differently depending on their protein environments. Breast tumor cells in a tumorous environment (left) rapidly exited the tumor fragment. Breast tumor cells in a healthy environment (right) grew in a controlled manner. Credit: Kevin Cheung, M.D.

(Medical Xpress)—A new study from Johns Hopkins researchers suggests that the lethal spread of breast cancer is as dependent on a tumor's protein-rich environment as on genetic changes inside tumor cells.

In a report in the Sept. 25 issue of the , the scientists conclude that a molecular signal in the protein meshwork surrounding the may provide the critical trigger to initiate the life-threatening process of metastasis to distant sites in the body.

Moreover, their experiments suggest that the environment surrounding a tumor can even coax healthy to invade surrounding tissue just as cancer cells do, and that a healthy environment can cause cancer cells to stay put and not spread as they usually do.

"The most dangerous aspect of is its ability to spread to distant sites, and most tumors are initially unable to do that," says Andrew Ewald, Ph.D., assistant professor of at the Johns Hopkins School of Medicine and member of the Institute for Basic Biomedical Sciences' Center for . Learning more specifically what triggers metastases may provide additional targets for preventing and treating the malignant process that causes cancer deaths, Ewald adds.

It's widely accepted that cancers acquire the ability to spread through the gradual accumulation of , and experiments have also shown that these changes occur in parallel with changes in the and 3-dimensional patterning of the protein meshwork that creates their immediate surroundings. What has been unclear is whether those immediate surroundings play a role in initiating and encouraging cancer's spread, or whether they are more "effect" then "cause."

To sort out the contributions of both the genetic changes and the environment, Ewald's team separated from their surroundings by taking fragments of human breast tumors and embedding them in two different commercially available 3-D gels, one that mimics the protein meshwork surrounding healthy mammary tissue and another that mimics tumorous mammary tissue.

The gels are tools often used to study tumor invasiveness. The first was made of proteins that normally create a thin layer around healthy breast tissue, acting as a molecular boundary for it. The second was made entirely of a protein, collagen I, which is found in unusually high concentrations around .

If cancer cells are driven to disperse solely because of the genetic changes they carry, the researchers expected to see the tumor fragments behave similarly in both the healthy and tumorous environments. What they saw instead, says Ewald, was a distinct difference. As expected, 88 percent of tumor fragments sent cells crawling into the tumorous meshwork environment, the first step in metastasis known as dissemination. (See video) But only 15 percent of tumor fragments sent cells crawling into the normal environment. (See video) According to Ewald, these results indicate that the environment around a tumor plays a more direct role in cancer spread than previously thought.

If indeed cells can be enticed outward by the protein environment, the researchers reasoned, that environment might even be powerful enough to coax cells away from healthy breast tissue. To test this idea, they took fragments of both healthy and cancerous mouse mammary glands and placed them in the collagen I gels mimicking a tumor's environment. Results show that in the tumorous environment, nearly as many of the healthy fragments sent cells dispersing (See video) as did the tumorous fragments (See video).

One notable difference shown in their time-lapse videos was that healthy cells only exited the normal tissue fragments for a short period of time, while continued to exit the tumor fragments throughout the whole test period.

To learn why healthy cells stopped exiting normal tissue fragments sooner, the researchers analyzed the proteins on the cells that were in direct contact with the meshwork gels. In breast tissue, a thin protein layer normally forms a boundary between cells and their environment. When both healthy and tumorous tissue fragments were surgically removed prior to the experiments, this boundary was disrupted, allowing breast to directly contact the protein meshwork beyond the boundary. In healthy mammary gland fragments, the team found that the "self-corrective behavior" coincided with the re-creation of this protein boundary.

"This tells us that tumors continue to listen to their environments," Ewald says. "Our data suggest that tumors with genetic changes that favor cancer spread may not disperse until they are within a permissive environment." A dispersal-permissive is enough to provoke invasive behavior in all mammary tissue, healthy and cancerous, Ewald explains, and the difference between the two can be a single genetic change that allows the dispersal to continue unchecked.

Journal reference: Proceedings of the National Academy of Sciences search and more info website

Provided by Johns Hopkins University School of Medicine search and more info website

5 /5 (2 votes)  

Rank 5 /5 (2 votes)
Relevant PhysicsForums posts

More news stories

Small cancer risk following CT scans in childhood and adolescence confirmed

The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...

Cancer created 8 hours ago | popularity not rated yet | comments 0

Changing cancer's environment to halt its spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...

Cancer created 9 hours ago | popularity not rated yet | comments 0

Novel RNA-based classification system for colorectal cancer

A novel transcriptome-based classification of colon cancer that improves the current disease stratification based on clinicopathological variables and common DNA markers is presented in a study published in PLOS Medicine this w ...

Cancer created 10 hours ago | popularity not rated yet | comments 0

Low radiation scans help identify cancer in earliest stages

A study of veterans at high risk for developing lung cancer shows that low-dose computed tomography (LDCT) can be highly effective in helping clinicians spot tiny lung nodules which, in a small number of patients, may indicate ...

Cancer created 11 hours ago | popularity not rated yet | comments 0

Poliovirus vaccine trial shows early promise for recurrent glioblastoma

An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.

Cancer created 13 hours ago | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.